Drug
Vincristine clinical trials
Also written Oncovin, VCR, Vincrex and NSC-67574.
Includes 12 studies of Vincristine Sulfate Liposome and 5 studies of Vincristine Liposomal.
- studies test it
- 358
- open now
- 45
- in phase 3
- 88
- first study started
- 1990
Keep track of what changes. Save the Vincristine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Other names
- VCR
- 54
Studies by the year they started
349 studies that test it; most in 2004 (24)
| Year | Studies |
|---|---|
| 1990 | 1 |
| 1992 | 2 |
| 1993 | 2 |
| 1994 | 3 |
| 1995 | 6 |
| 1996 | 12 |
| 1997 | 6 |
| 1998 | 18 |
| 1999 | 9 |
| 2000 | 9 |
| 2001 | 9 |
| 2002 | 13 |
| 2003 | 18 |
| 2004 | 24 |
| 2005 | 11 |
| 2006 | 11 |
| 2007 | 15 |
| 2008 | 15 |
| 2009 | 14 |
| 2010 | 8 |
| 2011 | 10 |
| 2012 | 9 |
| 2013 | 12 |
| 2014 | 6 |
| 2015 | 10 |
| 2016 | 13 |
| 2017 | 6 |
| 2018 | 11 |
| 2019 | 8 |
| 2020 | 9 |
| 2021 | 8 |
| 2022 | 10 |
| 2023 | 7 |
| 2024 | 8 |
| 2025 | 8 |
| 2026 | 8 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 4
- Phase 1
- 71
- Phase 2
- 192
- Phase 3
- 88
- Phase 4
- 11
- No phase
- 20
What it is tested for
Each study’s main condition, where its own words name it.
- Lymphoma
- 30
Who runs them
Industry 39 · Other 319
Children's Oncology Group (50) · National Cancer Institute (NCI) (27) · St. Jude Children's Research Hospital (24) · M.D. Anderson Cancer Center (15) · Memorial Sloan Kettering Cancer Center (8) · SWOG Cancer Research Network (7) · Acrotech Biopharma Inc. (6) · Alliance for Clinical Trials in Oncology (6)
Often tested with
Tested in the same studies.
Cyclophosphamide (204) · Doxorubicin (158) · Prednisone (124) · Etoposide (111) · Methotrexate (77) · Dexamethasone (73) · Cytarabine (67) · Rituximab (65)
Studies
Open first, then newest update. How each study uses Vincristine is read from its arms, and is right about nine times in ten.
Testing it · 358
- A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and NivolumabRecruitingPhase 3National Cancer Institute (NCI)NCT05675410Written as Vincristine Sulfate
- Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell LymphomaRecruitingPhase 2National Cancer Institute (NCI)NCT04002947Written as CHOP
- A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell LymphomaRecruitingPhase 2University of RochesterNCT03758989Written as Vincristine
- PEEL-224, Vincristine and Temozolomide in Pediatric Solid TumorsRecruitingPhase 1/2Theodore LaetschNCT06721689Written as Vincristine
- Metastatic Ewing's Trial Testing Schedule Enhancement to Improve OutcomesRecruitingPhase 1H. Lee Moffitt Cancer Center and Research InstituteNCT07194044Written as Vincristine
- Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed MedulloblastomaRecruitingPhase 2St. Jude Children's Research HospitalNCT05535166Written as Vincristine
- N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With NeuroblastomaRecruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT06528496Written as Vincristine
- A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)RecruitingPhase 3Children's Oncology GroupNCT06401330Written as Vincristine
- Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)RecruitingPhase 3Children's Oncology GroupNCT03126916Written as Vincristine Sulfate
- A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWTRecruitingPhase 2Children's Oncology GroupNCT04322318Written as Vincristine
- Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary BlastomaRecruitingPhase 3Children's Oncology GroupNCT06647953Written as Vincristine
- Testing the Addition of a New Anti-Cancer Drug, Glofitamab to Usual Chemotherapy for Burkitt and Double Hit LymphomaNot yet recruitingPhase 2/3National Cancer Institute (NCI)NCT07724457Written as Vincristine
- ALL Backbone in AYAsRecruitingPhase 2Dana-Farber Cancer InstituteNCT07227584Written as Vincristine
- Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent SarcomaRecruitingNot applicableM.D. Anderson Cancer CenterNCT04199026Written as Vincristine
- Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in ChildrenRecruitingPhase 2Hee Young JuNCT06099366Written as induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal Methotrexate
- The CARDIOPROTECT TrialRecruitingPhase 2Beth Israel Deaconess Medical CenterNCT07654426Written as Vincristine
- Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and LymphomaRecruitingPhase 2St. Jude Children's Research HospitalNCT06533748Written as Vincristine
- Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/LymphomaRecruitingPhase 4St. Jude Children's Research HospitalNCT06289673Written as Vincristine
- Immuno-Targeted Therapy Plus Low-Dose Chemotherapy for Newly Diagnosed Adult Ph-Negative B-ALL: A Prospective Umbrella TrialNot yet recruitingPhase 2Institute of Hematology & Blood Diseases Hospital, ChinaNCT07643103Written as Vincristine
- Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)RecruitingPhase 2University of ChicagoNCT04747912Written as Vincristine
See all 358 studies that test Vincristine →
Given in every arm · 424 — Vincristine is usual care beside what is tested
- A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)RecruitingPhase 2National Cancer Institute (NCI)NCT06124157Written as Vincristine
- Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged LeukemiaRecruitingPhase 2National Cancer Institute (NCI)NCT06317662Written as Vincristine
- Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk NeuroblastomaRecruitingPhase 3National Cancer Institute (NCI)NCT06172296Written as Vincristine
- Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell PhenotypeRecruitingPhase 3Chipscreen Biosciences, Ltd.NCT06947967Written as CHOP (cyclophosphamide, hydroxydaunorubicin [doxorubicin], Oncovin [vincristine], prednisone)
- Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic LeukemiaRecruitingPhase 3Alliance for Clinical Trials in OncologyNCT03150693Written as Vincristine Sulfate
- Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK StudyNot yet recruitingPhase 2AIDS Malignancy ConsortiumNCT07662928Written as Vincristine
- Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic LeukemiaRecruitingPhase 1City of Hope Medical CenterNCT07133997Written as Vincristine
- Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)RecruitingPhase 1National Cancer Institute (NCI)NCT04301076Written as Vincristine Sulfate
- Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)RecruitingPhase 1/2Novartis PharmaceuticalsNCT07387926Written as Vincristine
- A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)RecruitingPhase 2/3Merck Sharp & Dohme LLCNCT07634471Written as Vincristine
- Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More TreatmentNot yet recruitingPhase 2SWOG Cancer Research NetworkNCT07636564Written as Vincristine
- Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaRecruitingPhase 2City of Hope Medical CenterNCT06918431Written as Vincristine Sulfate
- Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID TrialRecruitingPhase 3SWOG Cancer Research NetworkNCT07220187Written as Vincristine
- Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaRecruitingPhase 2M.D. Anderson Cancer CenterNCT00501826Written as Vincristine Sulfate
- A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell LymphomaRecruitingPhase 3Regeneron PharmaceuticalsNCT06091865Written as Vincristine
- Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid TumorsRecruitingPhase 1/2Milton S. Hershey Medical CenterNCT06541262Written as Vincristine
- Eflornithine (DFMO) for Ewing Sarcoma and OsteosarcomaRecruitingPhase 2Milton S. Hershey Medical CenterNCT07321912Written as Vincristine
- Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell LymphomaRecruitingPhase 2Alliance for Clinical Trials in OncologyNCT04803201Written as Vincristine
- Loncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP) for Naïve High-Risk Diffuse Large B-cell Lymphoma (DLBCL)RecruitingPhase 1The University of Texas Health Science Center at San AntonioNCT06977711Written as Vincristine
- A Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of Golidocitinib in the Management of Newly Diagnosed Peripheral T Cell Lymphoma Patients (GOLDEN Study) and Correlative StudyRecruitingPhase 2M.D. Anderson Cancer CenterNCT06630091Written as Vincristine
Showing 20 of 424.
As the comparator · 49 — what is tested is compared with Vincristine
- A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)RecruitingPhase 3Merck Sharp & Dohme LLCNCT06717347Written as Vincristine
- A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular LymphomaRecruitingPhase 3Regeneron PharmaceuticalsNCT06091254Written as Vincristine
- A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade GliomaRecruitingPhase 3National Cancer Institute (NCI)NCT04166409Written as Vincristine Sulfate
- A Multicenter, Prospective, Open-Label, Randomized Controlled Clinical Study of Orelabrutinib Combined With Obinutuzumab and Lenalidomide Versus Obinutuzumab Plus Chemotherapy for Treatment-Naive Follicular LymphomaNot yet recruitingPhase 3Ruijin HospitalNCT07719855Written as Vincristine
- Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone LymphomaRecruitingPhase 3The Lymphoma Academic Research OrganisationNCT06006117Written as CHOP (cyclophosphamide, hydroxydaunorubicin [doxorubicin], Oncovin [vincristine], prednisone)
- A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)RecruitingPhase 3CelgeneNCT06911502Written as Vincristine
- Doxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical StudyRecruitingPhase 2Sun Yat-sen UniversityNCT05457829Written as Temozolomide+Irinotecan+Vincristine
- Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapyRecruitingPhase 2University of BirminghamNCT05848765Written as Vincristine
- Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for LymphomaRecruitingPhase 3The Affiliated People's Hospital of Ningbo UniversityNCT06520163Written as CHOP
- Orelabrutinib Combined With Rituximab Versus R-CVP in the Untreated MZL： A Randomized, Open Phase II TrialRecruitingPhase 2Fei LiNCT06700798Written as Vincristine
- Obinutuzumab With CHOP Versus Obinutuzumab With Bendamustine in the Treatment of Newly Diagnosed Follicular Lymphoma Grade 3ANot yet recruitingPhase 2Sun Yat-sen UniversityNCT06961500Written as CHOP
- A Study Comparing the Efficacy and Safety of Pola-RCHP-X Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With DLBCLNot yet recruitingPhase 2The First Affiliated Hospital with Nanjing Medical UniversityNCT06516978Written as Vincristine
- Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic TumorRecruitingPhase 3Weiguo LvNCT02639650Written as vincristine
- CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell LymphomaTerminatedPhase 2Emergent BioSolutionsNCT00893516Written as CHOP
- Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5Active, not recruitingPhase 3The Lymphoma Academic Research OrganisationNCT06284122Written as Vincristin
- Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell TumorsCompletedPhase 2St. Jude Children's Research HospitalNCT01946529Written as vincristine
- A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade GliomaActive, not recruitingPhase 3National Cancer Institute (NCI)NCT03871257Written as Vincristine Sulfate
- Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and AdolescentsActive, not recruitingPhase 3Dana-Farber Cancer InstituteNCT03020030Written as Vincristine
- Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular LymphomaActive, not recruitingPhase 2National Cancer Institute (NCI)NCT03269669Written as Vincristine Sulfate
- Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell LymphomaActive, not recruitingPhase 3Kite, A Gilead CompanyNCT05605899Written as Vincristine
Showing 20 of 49.
Codes
What other systems call Vincristine · ClinicalTrials.gg INT008409
- MeSH (NLM) D014750VincristineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 5J49Q6B70FVINCRISTINEConfirmed FDA, NLM, Wikidata
- RxNorm 11202Confirmed FDA, Wikidata
- Wikidata Q408977vincristineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C933VincristineConfirmed FDA, Wikidata
- DrugBank DB00541One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D014750 | Vincristine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 5J49Q6B70F | VINCRISTINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 11202 | — | Confirmed FDA, Wikidata |
| Wikidata | Q408977 | vincristine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C933 | Vincristine | Confirmed FDA, Wikidata |
| DrugBank | DB00541 | — | One source Wikidata |
Also registered as vincristine sulfate (UNII T5IRO3534A · RxNorm 11203).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.